KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Debt to Equity (2016 - 2026)

Medtronic's Debt to Equity history spans 13 years, with the latest figure at $0.57 for Q1 2026.

  • For Q1 2026, Debt to Equity rose 6.86% year-over-year to $0.57; the TTM value through Jan 2026 reached $0.57, up 6.86%, while the annual FY2024 figure was $0.5, 5.25% up from the prior year.
  • Debt to Equity for Q1 2026 was $0.57 at Medtronic, down from $0.6 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.6 in Q4 2025 and bottomed at $0.44 in Q3 2022.
  • The 5-year median for Debt to Equity is $0.51 (2022), against an average of $0.52.
  • The largest annual shift saw Debt to Equity decreased 12.6% in 2022 before it grew 19.74% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.51 in 2022, then dropped by 5.03% to $0.49 in 2023, then rose by 19.74% to $0.58 in 2024, then increased by 2.44% to $0.6 in 2025, then dropped by 3.79% to $0.57 in 2026.
  • Per Business Quant, the three most recent readings for MDT's Debt to Equity are $0.57 (Q1 2026), $0.6 (Q4 2025), and $0.59 (Q3 2025).